Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer

SAN DIEGO, Feb. 12, 2024. Kintara Therapeutics, Inc. ( " Kintara " or the " Company " ), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced the initiation of a REM-001 15-patient clinical trial...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials